EVH vs UNH

EVH exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a significant YoY revenue decline of 27.50%. While the stock trades at a low Price-to-Book (0.84) and Price-to-Sales (0.19) ratio, these metrics likely represent a value trap given the negative profit margins (-28.49%) and high debt-to-equity ratio (2.38). Despite a 'Strong Buy' analyst consensus and a target price of $5.18, the deterministic data and long-term price performance (-85.2% over 5 years) suggest a high-risk profile with failing operational momentum.

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.